v3.26.1
Segment Reporting
6 Months Ended
Jun. 30, 2026
Segment Reporting

Note 5 - Segment Reporting

 

The Company operates through three reportable segments:

 

 

·

Honey straw manufacturing

 

·

Pharmaceutical and dietary supplements manufacturing

 

·

Building and construction services

 

These segments are determined based on the information regularly reviewed by the Company’s Chief Operating Decision Maker (“CODM”), identified as the Chief Executive Officer, for purposes of allocating resources and assessing performance.

 

The CODM evaluates segment performance primarily based on revenue and segment gross profit. Segment gross profit represents revenue less cost of revenue and direct operating expenses.

 

The Company’s segments utilize certain centralized functions, including procurement, administrative support, and quality control; however, financial performance is assessed separately for each reportable segment.

 

Business Segments

 

Honey Straw Manufacturing

 

 

Pharmaceutical and Dietary Supplement Manufacturing

 

 

Building and construction Services

 

6-month Period Ended June 30

 

2025

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

2026

 

Revenue

 

$955,279

 

 

$914,850

 

 

$959,894

 

 

$898,910

 

 

$3,516,999

 

 

$3,821,955

 

Cost and Expenses

 

$(1,053,168)

 

$(1,134,560)

 

$(697,805)

 

$(934,267)

 

$(2,800,955)

 

$(3,889,065)

Profit / Loss

 

$(97,889)

 

$(219,710)

 

$262,089

 

 

$(35,357)

 

$716,044

 

 

$(67,110)

 

3-month Period Ended June 30

 

2025

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

2026

 

Revenue

 

$487,204

 

 

$447,000

 

 

$563,011

 

 

$450,611

 

 

 

1,980,260

 

 

$2,004,987

 

Cost and Expenses

 

$(335,490)

 

$(404,850)

 

$(387,892)

 

$(408,268)

 

$(1,364,302)

 

$(1,815,781)

Profit / Loss

 

$151,714

 

 

$42,150

 

 

$175,119

 

 

$42,343

 

 

$615,958

 

 

$189,206

 

 

The significant expense categories are regularly provided to the CODM and included in the measure of segment profit on the Cost of Material and Labor. However, the General and Administrative Expenses, which consist of expenses not distinctively separable are allocated based on estimates shown above.

 

RECONSOLIDATED SEGMENTED STATEMENT OF OPERATIONS

 

 

 

6-month Period Ended June 30

 

 

3-month Period Ended June 30

 

 

 

2025

 

 

2026

 

 

2025

 

 

2026

 

 

 

US$

 

 

US$

 

 

US$

 

 

US$

 

Revenue

 

 

 

 

 

 

 

 

Honey Straw Manufacturing

 

 

955,279

 

 

 

914,850

 

 

 

487,204

 

 

 

447,000

 

Pharmaceutical and Dietary Supplements Manufacturing

 

 

959,894

 

 

 

898,910

 

 

 

563,011

 

 

 

450,611

 

Building and Construction Services

 

 

3,516,999

 

 

 

3,821,955

 

 

 

1,980,260

 

 

 

2,004,987

 

Total Revenue

 

 

5,432,172

 

 

 

5,635,715

 

 

 

3,030,475

 

 

 

2,902,598

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Honey Straw Manufacturing

 

 

(409,676)

 

 

(507,510)

 

 

(162,059)

 

 

(208,101)

Pharmaceutical and Dietary Supplements Manufacturing

 

 

(410,143)

 

 

(498,755)

 

 

(187,373)

 

 

(209,859)

Building and Construction Services

 

 

(1,510,538)

 

 

(2,120,725)

 

 

(659,030)

 

 

(933,349)

Total Cost of Revenue

 

 

(2,330,357)

 

 

(3,126,990)

 

 

(1,008,462)

 

 

(1,351,309)

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit / loss

 

 

3,101,815

 

 

 

2,508,725

 

 

 

2,022,013

 

 

 

1,551,289

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

(2,221,571)

 

 

(2,830,902)

 

 

(1,079,222)

 

 

(1,277,590)

Profit/Loss Before Income Tax

 

 

880,244

 

 

 

(322,177)

 

 

942,791

 

 

 

273,699

 

Income tax expenses

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net Profit/Loss

 

 

880,244

 

 

 

(322,177)

 

 

942,791

 

 

 

273,699

 

 

The Company’s total revenue by business activity is as follows:

 

 

 

Period Ended

June 30, 2025

 

 

Period Ended

June 30, 2026

 

Honey Straw Manufacturing

 

 

18%

 

 

16%

Pharmaceutical and Dietary Supplements Manufacturing

 

 

18%

 

 

16%

Building and Construction Services

 

 

64%

 

 

68%